Related references
Note: Only part of the references are listed.Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae
Young R. Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
Konstantinos Z. Vardakas et al.
LANCET INFECTIOUS DISEASES (2018)
Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient
Nuria Piedra-Carrasco et al.
MICROBIAL DRUG RESISTANCE (2018)
Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
M. Souli et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp)
Alessandra Oliva et al.
JOURNAL OF INFECTION (2017)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice
Veena Venugopalan et al.
INFECTIOUS DISEASES (2017)
Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
Wasim S. El Nekidy et al.
IDCASES (2017)
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study
Gennaro De Pascale et al.
CRITICAL CARE (2017)
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Jessica B. Cprek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis A Meta-analysis of Individual Patient Data from Randomized Trials
Jason A. Roberts et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
CLINICAL INFECTIOUS DISEASES (2016)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2016)
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
A. Oliva et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia
Jose F. Camargo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Managing a nosocomial outbreak of carbapenem-resistant Klebsiella pneumoniae: an early Australian hospital experience
L. W. K. Chang et al.
INTERNAL MEDICINE JOURNAL (2015)
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen
Alessandra Oliva et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae
Nathalie Grace Chua et al.
JOURNAL OF INFECTION (2015)
Treating infections caused by carbapenemase-producing Enterobacteriaceae
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
Konstantinos Pontikis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
Alessandra Oliva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae
Giancarlo Ceccarelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
Helen Giamarellou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae
Kenneth S. Thomson
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Klebsiella oxytoca in Austria
Martin Hoenigl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
Grace C. Lee et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2012)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Abraham Borer et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France
T Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Share Paper
